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Les microparticules (MP) sont des fragments de membrane 
désormais reconnus comme marqueurs  ables de l’activation et de 
l’apoptose cellulaires.
Objectif — Notre objectif a été de déterminer si les taux de MP 
issues de différents types cellulaires étaient associés à la sévérité 
des lésions athéromateuses et à la récurrence d’événements 
cardiovasculaires chez des patients coronariens.
Méthodes et Résultats — Les taux plasmatiques de MP ont été 
mesurés par cytométrie en  ux chez 172 patients en attente de 
coronarographie à l’hôpital de la Timone. 77 patients (46 %) ont 
béné cié d’une pose de stent et ont été suivis durant 1 mois. 
12 événements récurrents ont été rapportés pendant la période 
de suivi. Dans la cohorte totale, les taux de MP positives pour le 
marqueur d’activation leucocytaire CD11b (MPCD11b+) étaient 
signi cativement plus élevés chez les patients traités par des 
statines (p = 0,001) et chez les patients ayant une fraction d’éjection 
préservée (p = 0,02). Les taux de MPCD11b+ étaient signi cativement 
mais négativement associés à l’étendue des lésions athéromateuses 
coronaires évaluée par les données angiographiques et par le 
Syntax Score, ceci même après ajustement sur le traitement par 
les statines et sur la fraction d’éjection (p = 0,005). Au sein de la 
population stentée, les taux de MPCD11b+ étaient signi cativement 
inférieurs chez les patients ayant présenté un événement récurrent 
(p = 0,0001). Cette différence restait signi cative après ajustement 
sur le Syntax Score, sur la fraction d’éjection et sur le traitement 
par des statines (p = 0,03).
Conclusion — Les MPCD11b+ sont un marqueur biologique qui 
permet d’identi er les patients coronariens à haut risque de 
récurrence indépendamment de la sévérité des lésions observées 
lors de la coronarographie.
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Recent studies have demonstrated that microparticles (MPs) 
generated from T lymphocytes undergoing both activation and 
apoptosis correct endothelial injury, and regulate angiogenesis. 
These effects are mediated by an increase of NO release and a 
decrease of reactive oxygen species (ROS) production. Apoptosis 
is an important mechanism that controls endothelial cell number 
and regeneration. We studied the effects of these MPs on human 
umbilical vein endothelial cell (HUVEC) apoptosis induced by 
actinomycin D (actD). Engineered MPs were obtained by activation 
of human lymphocyte CEM-T cell line with phytohemagglutinin and 
then, by stimulation with phorbol-12-myristate-13-acetate and 
actD. HUVECs were grown for 24h in absence or presence of the 
proapoptotic agent actD (1 g/ml), and/or 10 g protein/ml of MPs. 
In another set of experiments, endothelial cells were pre-incubated 
either with nonselective caspases inhibitor, z-vad.fmk (50 m), PI3-
kinase inhibitor, LY294002 (10 m), ERK inhibitor, U0126 (10 m), 
NOS inhibitor, L-NA (100 m), or the superoxide dismutase (SOD) 
mimetic, manganese(III)tetrakis-(1-methyl-4-pyridyl)-porphyrin 
pentachloride (MnTMPyP, 100 m). The proportion of nuclei with 
hypodiploid DNA (sub-G1 peak) corresponding to apoptotic cells 
was determined by  ow cytometry after staining with propidium 
iodide, and by microscopy using TUNEL labeling. Our results clearly 
indicate that activated/apoptotic T lymphocytes MP treatment 
signi cantly reduces HUVEC apoptosis evoked by actD. Moreover, 
pancaspases inhibitor reduces the degree of cell death either 
in presence or in absence of MPs, indicating the implication of 
caspases in actD-induced apoptosis. Although, the PI3-kinase 
inhibitor induces apoptosis by itself, it does not blunt the capacity 
of MPs in reducing apoptosis induced by actD. In contrast, the 
inhibitory effect of MPs is prevented in the presence either of the 
ERK inhibitor or the NOS inhibitor. Interestingly, MnTMPyP reduces 
actD-evoked apoptosis and the protective effects of MPs. Thus, 
these MPs may act as an SOD mimetic under these experimental 
conditions. Altogether, T lymphocyte MPs evoked cell protection 
against apoptosis at the level of caspases inhibition, MAP kinases, 
NO and ROS formations. They underscore the potential therapeutic 
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Obstructive sleep apnea syndrome (OSAS) is a highly prevalent 
disease characterized by recurrent episodes of partial or complete 
obstruction of the upper airways during sleep, leading to oxygen 
desaturation, sleep fragmentation and clinical endothelial 
dysfunction. Microparticles (MPs) are membrane vesicles 
released during cell activation and apoptosis. Elevated levels 
of circulating MPs have been detected in pathologies associated 
with vascular alterations. We investigated the effects of MPs 
on endothelial function and vascular reactivity in OSAS. Blood 
samples were obtained either from 38 OSAS patients without 
any other cardiovascular comorbidities and 23 healthy subjects. 
A desaturation index above 10 per hour de ned OSAS patients. 
MPs concentration and origin were assessed using  ow cytometer. 
Male Swiss mice were injected i.v. with MPs from OSAS or healthy 
subjects, or with saline solution, and sacri ed after 24 hours. 
Endothelial function and vascular reactivity were studied on aortic 
rings and small mesenteric resistance (SMA) arteries by myography 
and arteriography, respectively. Patients with OSAS did not display 
increased circulating levels of MPs compared to healthy subjects 
including those from pro-coagulant, platelet, endothelial, leukocyte 
and erythrocyte origins. Interestingly, MPs from granulocytes and 
activated leukocytes were signi cantly enhanced in OSAS patients. 
Activated leukocyte MPs positively correlated with oxygen 
desaturation index. In aorta, MPs from OSAS patients but not those 
from healthy subjects signi cantly reduced endothelium-dependent 
relaxation to acetylcholine. MPs from OSAS increased sensitivity of 
the aorta in response to serotonin that was greater compared to 
the effect of MPs from healthy subjects. In SMA, MPs from OSAS 
but not those from healthy subjects impaired  ow-induced dilation 
without any effect on myogenic tone. Although SMA from mice 
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treated with healthy subjects MPs did not affect  ow-induced 
dilation, these vessels showed a reduced prostacyclin-component 
that was completely compensated by the NO-component of the 
response. The endothelial dysfunction induced by MPs from OSAS 
was caused by the reduction of both NO- and prostacyclin- but 
not the endothelium-derived hyperpolarizing factor-components of 
the response in SMA. These data provide evidence that circulating 
MPs from OSAS patients in uence both endothelial function and 
vascular reactivity.
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During cell activation or apoptosis, cells release vesicles, also 
called microparticles (MPs) from the plasma membrane. Since 
composition of MPs is dependent on cell origin and the type of 
stimulation, we compared the effects of MPs generated from both 
apoptotic T lymphocytes and apoptotic monocytes on endothelial 
function with respect to both nitric oxide (NO) pathway and 
reactive oxygen species (ROS). MPs were produced by treatment of 
either human T lymphocytes with the apoptotic agent actinomycin 
D or human monocytic cell line THP-1 with the apoptotic agent, 
the etoposide VP-16. Human Eahy 926 endothelial cells were 
incubated with 10 g/ml MPs for 24h. Apoptotic MPs from human 
T lymphocytes decreased NO production that was associated 
with overexpression and phosphorylation of endothelial NO-
synthase (eNOS). Also, T lymphocytes MPs enhanced expression 
of caveolin-1 and decreased its phosphorylation. T lymphocytes 
MPs enhanced ROS by a mechanism sensitive to xanthine oxidase 
and P-IkappaBalpha inhibitors. PI3-kinase inhibition reduced the 
effects of T lymphocytes MPs on eNOS, but not on caveolin-1, 
whereas it enhanced the effects of MPs on ROS production. 
Inhibition of MEK reversed eNOS phosphorylation but it had 
no effect on ROS production induced by T lymphocytes MPs. 
By contrast, apoptotic MPs from human monocytes increased 
both NO production and in much less extent ROS. These effects 
were associated with a decrease of caveolin-1 expression and 
increased its phosphorylation, without affecting eNOS expression 
and phosphorylation. The inhibitor of the PI-3kinase, LY294002, 
reversed the effects of monocyte MPs on caveolin-1 expression 
but not on its phosphorylation. The MEK1/2 inhibitor, U0126, 
reversed the decrease of caveolin-1 expression induced by MPs 
from monocytes. Interestingly, U0126 potentiated ROS production 
induced by monocyte MPs. Whereas in vivo injection of T 
lymphocytes MPs in mice impaired endothelial function, apoptotic 
MPs from human monocytes did not affect endothelium-dependent 
relaxation. In addition, monocyte MPs were able to promote in 
vitro angiogenesis. In summary, these results highlight differential 
effects of apoptotic MPs from different origins by activating 
diverse multiple pathways related to NO and ROS productions.
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Telomerase, a ribonucleoprotein enzyme, catalyses the synthesis 
of repeated telomeric sequences. Telomeres are required for 
chromosome stability and cell viability and a decrease of their 
length was found to be associated with several cardiovascular 
diseases. Telomerase contains the hTR RNA, and several proteins, 
including the reverse transcriptase hTERT. The hTR 5’ domain 
contains the template sequence for DNA synthesis and binds hTERT. 
The H/ACA 3’ domain is required for stability and associates with 
4 proteins (Dyskerin, GAR1, NOP10 and NHP2 proteins). Limited 
information is available on telomerase assembly. A pre-complex 
containing Dyskerine, NOP10, NHP2 and an assembly factor, called 
NAF1, is likely formed in the cytoplasm and transported to the 
nucleus, where it associates with the H/ACA domain of nascent 
RNA. Exchange of NAF1 for GAR1 allows the production of the 
functional H/ACA RNP domain. We showed that several factors 
are implicated in H/ACA RNP assembly : NUFIP, the R2TP complex, 
and HSP90. The SMN complex, containing the SMN, Gemin2 to 
Gemin8 and Unrip proteins may also be involved, since protein SMN 
interacts with GAR1.
For further analysis on the role of the SMN complex in telomerase 
assembly, we tested by yeast two hybrid assays whether other 
proteins of this complex can interact with H/ACA RNP proteins 
and their assembly factors. We discovered a possible interaction 
between NAF1, Gemin 3 and Gemin8. Hence, the SMN complex may 
be involved in the replacement of NAF1 by GAR1 : it may associate 
with GAR1 through an interaction with SMN, and with the pre-H/
ACA RNP complex through interaction of NAF1 with Gemin3 and 
8, allowing the replacement of NAF1 by GAR1. We are testing this 
hypothesis. The SMN complex may also be involved in hTERT binding 
to the 5’ domain of hTR and we will also explore this possibility.
Through these studies we should bring insight into telomerase 
assembly that may be useful to understand telomere attrition in 
cardiovascular diseases.
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Contexte — Les MP sont générées par le remaniement de la 
membrane plasmique suite à l’activation des cellules sanguines ou 
des cellules endothéliales.
Objectif — Nous avons caractérisé les microparticules circulantes 
chez les patients atteints du syndrome des anticorps anti-
phospholipides (SAPL), thrombophilie acquise caractérisée par un 
risque augmenté de thromboses et de complications obstétricales. 
